V007-5547 Screening compound: 3-(7-ethyl-1H-indol-3-yl)-1-(piperidin-1-yl)-3-[3-(trifluoromethyl)phenyl]propan-1-one

V007-5547 Screening compound: 3-(7-ethyl-1H-indol-3-yl)-1-(piperidin-1-yl)-3-[3-(trifluoromethyl)phenyl]propan-1-one
V007-5547 Screening compound: 3-(7-ethyl-1H-indol-3-yl)-1-(piperidin-1-yl)-3-[3-(trifluoromethyl)phenyl]propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V007-5547
3-(7-ethyl-1H-indol-3-yl)-1-(piperidin-1-yl)-3-[3-(trifluoromethyl)phenyl]propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V007-5547

Molecular Formula

C25H27F3N2O (C25 H27 F3 N2 O)

Compound Name

3-(7-ethyl-1H-indol-3-yl)-1-(piperidin-1-yl)-3-[3-(trifluoromethyl)phenyl]propan-1-one

IUPAC name

3-(7-ethyl-1H-indol-3-yl)-1-(piperidin-1-yl)-3-[3-(trifluoromethyl)phenyl]propan-1-one

SMILES

CCc1cccc2c1[nH]cc2C(CC(N1CCCCC1)=O)c1cccc(C(F)(F)F)c1

InChI

InChI=1S/C25H27F3N2O/c1-2-17-8-7-11-20-22(16-29-24(17)20)21(15-23(31)30-12-4-3-5-13-30)18-9-6-10-19(14-18)25(26,27)28/h6-11,14,16,21,29H,2-5,12-13,15H2,1H3/t21-/m1/s1

InChI Key

XAGCXAZJVBKRIK-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD19850978

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.5

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

6.101

Distribution Coefficient, logD

6.101

Water Solubility, LogSw

-5.80

Polar Surface Area

26.729

Acid Dissociation Constant (pKa)

18.17

Base Dissociation Constant (pKb)

-0.20

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

V007-5547 in Drug Discovery

Included in Screening Libraries

Glucocorticoid receptors Library (4806 compounds)

Indole Derivatives (10091 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with V007-5547 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V007-5547?
Check Price and Availability of V007-5547, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V007-5547 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V007-5547
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V007-5547
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V007-5547 available by request